Literature DB >> 23403560

Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells.

Hye Jin Choi1, Juil Kim, Kee Hun Do, Seong-Hwan Park, Yuseok Moon.   

Abstract

Intestinal epithelial activation of nuclear factor kappa B (NF-κB) exerts both detrimental and beneficial functions in response to various luminal insults, including ones associated with mucosa-associated pathogens. Gastrointestinal infection with enteropathogenic Escherichia coli (EPEC) causes severe injuries in epithelial integrity and leads to watery diarrhea. The present study was conducted to investigate the prolonged epithelial responses to persistent EPEC infection via NF-κB activation. EPEC infection led to sustained activation of NF-κB signal in mouse intestinal epithelial cells in vivo and in vitro, which was positively associated with a type III secretion system, whereas early NF-κB is regulated. Moreover, prolonged NF-κB activation was found to be a part of macrophage inhibitory cytokine 1 (MIC-1)-mediated signaling activation, a novel link between NF-κB signaling and infection-associated epithelial stress. EPEC infection induced gene expression of MIC-1, a member of the transforming growth factor β (TGF-β) superfamily, which then activated TGF-β-activated kinase 1 and consequently led to NF-κB activation. Functionally, both EPEC-induced MIC-1 and NF-κB signaling mediated epithelial survival by enhancing the expression of cyclin D1, a target of NF-κB. In summary, the results of the present study suggest that MIC-1 serves as a mediator of prolonged NF-κB activation, which is critical in maintaining gut epithelial integrity in response to infection-induced injuries.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403560      PMCID: PMC3676000          DOI: 10.1128/IAI.00162-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 2.  NF-kappaB and the intestine: friend or foe?

Authors:  Thomas Karrasch; Christian Jobin
Journal:  Inflamm Bowel Dis       Date:  2008-01       Impact factor: 5.325

3.  Proteomic analysis of glutamine-treated human intestinal epithelial HCT-8 cells under basal and inflammatory conditions.

Authors:  Sandrine Thébault; Nicolas Deniel; Rachel Marion; Roland Charlionet; François Tron; David Cosquer; Jérôme Leprince; Hubert Vaudry; Philippe Ducrotté; Pierre Déchelotte
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

4.  Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors.

Authors:  Mukesh K Agarwal; Kedar Hastak; Mark W Jackson; Samuel N Breit; George R Stark; Munna L Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-18       Impact factor: 11.205

5.  Mouse model of enteropathogenic Escherichia coli infection.

Authors:  Suzana D Savkovic; Jennilee Villanueva; Jerrold R Turner; Kristina A Matkowskyj; Gail Hecht
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 6.  Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer.

Authors:  Asne R Bauskin; David A Brown; Tamara Kuffner; Heiko Johnen; X Wei Luo; Mark Hunter; Samuel N Breit
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

7.  Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression.

Authors:  Thomas Y Ma; Michel A Boivin; Dongmei Ye; Ali Pedram; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-03       Impact factor: 4.052

8.  Utility of the Citrobacter rodentium infection model in laboratory mice.

Authors:  Diana Borenshtein; Megan E McBee; David B Schauer
Journal:  Curr Opin Gastroenterol       Date:  2008-01       Impact factor: 3.287

9.  Aged HCT-8 cell monolayers support Cryptosporidium parvum infection.

Authors:  Laura Y Sifuentes; George D Di Giovanni
Journal:  Appl Environ Microbiol       Date:  2007-10-12       Impact factor: 4.792

10.  Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function.

Authors:  Marie-Hélène Ruchaud-Sparagano; Marc Maresca; Brendan Kenny
Journal:  Cell Microbiol       Date:  2007-03-26       Impact factor: 3.715

View more
  7 in total

1.  Epithelial Cholesterol Deficiency Attenuates Human Antigen R-linked Pro-inflammatory Stimulation via an SREBP2-linked Circuit.

Authors:  Seong-Hwan Park; Juil Kim; Mira Yu; Jae-Hong Park; Yong Sik Kim; Yuseok Moon
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

2.  Mucosal ribosomal stress-induced PRDM1 promotes chemoresistance via stemness regulation.

Authors:  Juil Kim; Yuseok Moon
Journal:  Commun Biol       Date:  2021-05-10

3.  Enteropathogenic Escherichia coli Infection Inhibits Intestinal Ascorbic Acid Uptake via Dysregulation of Its Transporter Expression.

Authors:  Christopher W Heskett; Trevor Teafatiller; Carly Hennessey; Melanie G Gareau; Jonathan S Marchant; Hamid M Said; Veedamali S Subramanian
Journal:  Dig Dis Sci       Date:  2020-06-17       Impact factor: 3.487

4.  Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells.

Authors:  Feifei Xu; Fengliang Wang; Ting Yang; Yuan Sheng; Ting Zhong; Yun Chen
Journal:  Cancer Cell Int       Date:  2014-12-21       Impact factor: 5.722

5.  NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.

Authors:  Ki-Hyung Kim; Seong-Hwan Park; Kee Hun Do; Juil Kim; Kyung Un Choi; Yuseok Moon
Journal:  Oncotarget       Date:  2016-11-01

6.  GDF15 Regulates Malat-1 Circular RNA and Inactivates NFκB Signaling Leading to Immune Tolerogenic DCs for Preventing Alloimmune Rejection in Heart Transplantation.

Authors:  Yixin Zhang; Guangfeng Zhang; Yanling Liu; Renqi Chen; Duo Zhao; Vivian McAlister; Tina Mele; Kexiang Liu; Xiufen Zheng
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

7.  Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension.

Authors:  Stephen John Wort; Paul R Kemp; Benjamin E Garfield; Alexi Crosby; Dongmin Shao; Peiran Yang; Cai Read; Steven Sawiak; Stephen Moore; Lisa Parfitt; Carl Harries; Martin Rice; Richard Paul; Mark L Ormiston; Nicholas W Morrell; Michael I Polkey
Journal:  Thorax       Date:  2018-12-15       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.